May 16, 2012 – Silicon Bayou News
NuMe Health, the New Orleans-based biotech startup developing products that modify the bacteria that live in the gastrointestinal tract, today announced that it has closed a $1.5 million Series A financing.
NuMe Health Lands 1.5m Series A
Related Articles
BioChallenge 2026 Finalists Announced!
For Immediate Release New Orleans BioInnovation Center announces six finalists for BioChallenge 2026 Six companies developing innovations in brain health will compete for $100,000 in cash prizes Oct. 29 NEW…
NOBIC Tenant Spotlight: Exactics Brings Rapid at Home Diagnostics to Louisiana
NOBIC is proud to welcome Exactics to our growing community of innovators working to transform healthcare through biotechnology. Founded with the mission of making diagnostics faster, more accessible, and more…
Beken Bio awarded SBIR Phase II grant to advance ovarian cancer detection technology
FOR IMMEDIATE RELEASE: Beken Bio awarded SBIR Phase II grant to advance ovarian cancer detection technology Federal funding builds on company’s Phase I research and supports continued development of innovative…